3767 |
Venus P-Valve: Updating Outcomes |
Worakan Promphan |
Apr. 21. 16 |
3766 |
Enhancing CV Outcomes: Treat CV Risk Factors Not Just Cholesterol |
Jong-Young Lee |
Apr. 21. 16 |
3765 |
Growing Importance of Evidence in the Management of High CV Risk Patients |
Duk-Woo Park |
Apr. 21. 16 |
3764 |
Benefit of Adding Ezetimibe to Statin Therapy in ACS Patients |
Sang Yup Lim |
Apr. 21. 16 |
3763 |
Taped Case: PPVI (1) - Medtronic Melody Valve |
Jae Young Choi |
Apr. 21. 16 |
3762 |
Percutaneous Pulmonary Valve Replacement: State of the Art |
Damien Kenny |
Apr. 21. 16 |
3761 |
Efficacy of Ultimaster in CTO PCI¡¡ |
Yuji Hamazaki |
Apr. 21. 16 |
3760 |
Bifucation Case Review of Ultimaster |
Ho Kay Woon |
Apr. 21. 16 |
3759 |
Where Are We with PFO Closure? Long-Term Outcome from Randomized Trials |
Damien Kenny |
Apr. 21. 16 |
3758 |
Calcified Lesion - Debulking Followed by Bioresorablable Ploymer Stenting |
Tarun Dave |
Apr. 21. 16 |